Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) has become the most frequently encountered chronic liver disease. NAFLD is associated with increased liver-related morbidity and mortality, but also contributes to cardiovascular disease, diabetes and non-liver-related malignancy. Non-alcoholic steatohepatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Francque, Sven, Vonghia, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824365/
https://www.ncbi.nlm.nih.gov/pubmed/30888594
http://dx.doi.org/10.1007/s12325-019-00898-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824365/
https://www.ncbi.nlm.nih.gov/pubmed/30888594
http://dx.doi.org/10.1007/s12325-019-00898-6

Ejemplares similares